Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#123 / 123 Total
XFOR - X4 Pharmaceuticals Inc - Stock Price Chart
TickerXFOR [NASD, RUT]
CompanyX4 Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap15.46MEPS (ttm)2.24
P/E1.19EPS this Y-82.72%
Forward P/E-EPS next Y14.95%
PEG0.02EPS past 5Y47.41%
P/S0.49EPS next 5Y50.77%
P/B0.67EPS Q/Q100.53%
Dividend-Sales Q/Q-
Insider Own33.49%Inst Own29.32%
Insider Trans-8.42%Inst Trans-6.92%
Short Float10.34%EarningsMay 01/b
Analyst Recom1.00Target Price42.67
Avg Volume191.66K52W Range2.62 - 31.20
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baldry MarkChief Commercial OfficerMay 16 '25Buy2.481,0322,56125,337May 20 04:51 PM
Baldry MarkChief Commercial OfficerNov 15 '24Buy0.3413,4044,598129,173Feb 14 04:08 PM
Ragan PaulaPresident and CEOJan 24 '25Sale0.4576,47334,7191,087,386Jan 27 06:15 PM
Mostafa Adam S.Chief Financial OfficerJan 24 '25Sale0.4574,77333,9470Jan 27 06:15 PM
Baldry MarkChief Commercial OfficerJan 24 '25Sale0.4529,15913,24194,123Jan 27 06:15 PM
18910111213